openPR Logo
Press release

Contraceptive Sponges Market Analysis 2018-2025 Explored in Latest Research

Contraceptive Sponges Market Analysis 2018-2025 Explored

Contraceptive Sponges are generally soft foam sponges made of polyurethane with or without spermicide chemical to prevent the movement of sperm entering the uterus. It is normally 2 inch in diameter and has a loop for easy removal used by women to prevent pregnancy.

Demand Scenario

The global contraceptive sponges market was USD 27.96 million in 2018 and is estimated to reach USD 33 million by 2025 at a CAGR of 2.40% during the forecast period

Request For Report Sample: https://www.trendsmarketresearch.com/report/sample/3915

Growth by Region

North America leads the market with over 50% market share in 2018 owing to the rising awareness as well as high disposable income among people. Europe, on the other hand, is the second largest market due to the large presence of women increasingly using contraceptives to avoid pregnancies. Asia-Pacific region is also considered to be one of the lucrative markets for contraceptive sponges market globally bolstered by increasing government programs regarding family planning due to high population. Countries in South America, Middle-East and Africa also show an upsurge in growth during the projected timeframe owing to the increasing awareness through social media marketing thus serving as an impetus for retail and online stores to gain brand visibility in the region.

Request for Report Discount : https://www.trendsmarketresearch.com/report/discount/3915

Drivers vs Constraints

The global contraceptive sponges market is mainly driven by the increasing importance of family planning as well as rising awareness among women regarding the benefits of contraceptive sponges. However, the growth hindered by the inability of these birth control sponges to prevent sexually transmitted disease (STDs) and also due to the contraceptive sponges being not as effective as condoms.

Industry Trends and Updates

Mayor Laboratories, Inc., a US-based company which manufactures and sells healthcare and reproductive products has entered into an agreement with Blossom Organics, Inc. for the exclusive distribution of the company's naturally pure intimate care products to all retail, wholesale and governmental channels in United States, Europe and Canada.

Pirri Pharma Canada, Inc., a Canadian-based company which manufactures and sells healthcare and reproductive products has entered into an exclusive five-year supply agreement with Keata Pharma Inc. which is PharmaEng International Inc's., wholly-owned contract manufacturing subsidiary to provide commercial manufacturing and labelling of product Protectaid.

Make an Inquiry before Buying:https://www.trendsmarketresearch.com/checkout/3915/Single

Contact Us:

One Vincent Square
Westminster, London SW1P 2PN
United Kingdom Phone: +442033221521
Email: sales@trendsmarketresearch.com
Website: https://www.trendsmarketresearch.com

Company Overview

We are a UK-based market intelligence company that operates out of its passion to help brands grow, discover, and transform. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined - we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Contraceptive Sponges Market Analysis 2018-2025 Explored in Latest Research here

News-ID: 1917029 • Views: 115

More Releases for Pharma

Global Deferasirox Market 2018 - Novartis, Cipla, Sun Pharma, Natco Pharma
Apex Market Reports, recently published a detailed market research study focused on the “Deferasirox Market” across the global, regional and country level. The report provides 360° analysis of “Deferasirox Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Deferasirox on the basis of
Big Pharma Outlook 2026
Boston, MA ReportsWorldwide has announced the addition of a new report title Big Pharma Outlook 2026 to its growing collection of premium market research reports. Pharmavitae Analytics casts its eye out to 2026 with challenging trends in healthcare management set to crystallize, Big Pharma will add $29.5bn in revenues out to 2026, generating $351bn in prescription pharmaceuticals at a low single-digit compound annual growth rate (CAGR) of 0.9%. Using in-house sales forecasts,
Clomifene Citrate Market 2017 - Sanofi, Palam Pharma, Bioxera, Zafax Pharma
Apex Research, recently published a detailed market research study focused on the "Clomifene Citrate Market" across the global, regional and country level. The report provides 360° analysis of "Clomifene Citrate Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Clomifene Citrate industry, and estimates the future trend of Clomifene Citrate market on
12th World Pharma Congress
Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting in an abundant knowledge of the mechanisms driving drug discovery and development. Pharmaceutical Formulation Market size was USD $147billion in 2015 and is anticipated to reach around USD 175.1 billion by 2018. In USA, the total number of new drugs approved between
12th World Pharma Congress
Conference Series has taken an initiation to conduct International Pharma Congress worldwide. From several years Conference Series has been conducting Pharma Congress conferences in major continents like Europe, America and Asia Pacific. Previous conferences were held in city like USA, with success. Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting
4th African Pharma Congress
In the light of this theme, the conference series aims to provide a forum for international researchers from various areas of pharmaceutical sciences like chemical processing, industrial practice, analytical methods and pharmacological actions by providing a platform for critical analysis of new agenda, and to share latest cutting-edge research findings and results about all aspects of Pharmacy We are honoured to invite pharmacists, researchers, professors, scientific communities, delegates, students, business